The European Chemical Industry has set out on an ambitious path to become carbon neutral. Germany, as one of the major chemical manufacturing nations, has committed to...
As one glitch after another at Covid vaccine suppliers upends deliveries, the German federal government is drawing up plans to build up production within its borders...
With a new strategic platform for cell and gene therapy, Bayer aims to establish a leading position in this field while continuing to drive forward the transformation of...
Bayer has announced its intention to offload the Environmental Science Professional business as part of plans to accelerate the strategy implementation of its Crop...
Vaccines and treatments for Covid-19 continue to dominate global pharma market headlines. As the pandemic drags on, new issues continuously arise, some of them...
CureVac has agreed a collaboration with Bayer to speed up production and distribution of its Covid-19 vaccine candidate CVnCOV, which began clinical trials in December...
Through a subsidiary, Shanghai, China-based WuXi Biologics (WuXi Bio) is acquiring Bayer’s biologics substance plant at Wuppertal, Germany, for €150 million ($183.3...
